These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
309 related items for PubMed ID: 5968054
1. Clinical pharmacological studies with haloperidol. Dunlop E. J New Drugs; 1966; 6(4):243-6. PubMed ID: 5968054 [No Abstract] [Full Text] [Related]
2. [On the position of the butyrophenone derivative Haloperidol in psychiatric treatment]. Greger J, Glitschka A, Müller K. Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(7):241-52. PubMed ID: 5731879 [No Abstract] [Full Text] [Related]
3. Comparison of the therapeutic results of clothiapin and perphenazine in schizophrenia. Rodová A, Náhunek K, Svestka J. Act Nerv Super (Praha); 1971 Jun; 13(3):171-3. PubMed ID: 4939829 [No Abstract] [Full Text] [Related]
5. Long term haloperidol therapy in outpatients. Dunlop E. Int J Neuropsychiatry; 1967 Aug; 3():Suppl 1:87-94. PubMed ID: 4862423 [No Abstract] [Full Text] [Related]
6. Long-term effects of haloperidol. Man PL. Dis Nerv Syst; 1973 Feb; 34(2):113-8. PubMed ID: 4267586 [No Abstract] [Full Text] [Related]
7. Clinical experience with Melleril-Retard. Svestka J, Náhunek K. Act Nerv Super (Praha); 1970 Feb; 12(3):245-6. PubMed ID: 5457439 [No Abstract] [Full Text] [Related]
8. Clinical experience with octoclothepin. Rydzyński Z, Wierzbicki T. Act Nerv Super (Praha); 1970 Jan 12; 12(1):46-7. PubMed ID: 5418655 [No Abstract] [Full Text] [Related]
9. Clinical evaluation in 112 psychiatric patients of a butyrophenone neuroleptic, dehydrobenzperidol (R 4749). A controlled study in 45 patients of dehydrobenzperidol versus haloperidol. Cocito E, Ambrosini G, Arata A, Bevilacqua P, Tortora E. Arzneimittelforschung; 1970 Aug 12; 20(8):1119-25. PubMed ID: 4921409 [No Abstract] [Full Text] [Related]
10. [Experience with the butyrophenone preparation Luvatren in the therapy of schizophrenia]. Weiser G. Wien Med Wochenschr; 1968 May 11; 118(19):444-6. PubMed ID: 5702494 [No Abstract] [Full Text] [Related]
11. Clinical experience with fluspirilene in psychoses. Svestka J, Náhunek K, Hádlík J, Rodová A. Act Nerv Super (Praha); 1971 May 11; 13(3):173-4. PubMed ID: 5113825 [No Abstract] [Full Text] [Related]
12. [Comparative study of the activity of 2 neuroleptics]. Blanc M, Borenstein P, Brion S, Buisson JF, Debray HR, Digo R, Flavigny H, Follin S, Minvielle J, Morel-Maroger A, Pichot P, Rainaut J, Sutter JM. Encephale; 1970 May 11; 59(2):97-161. PubMed ID: 5458713 [No Abstract] [Full Text] [Related]
13. The clinical determination of unique effect of potentiation of phenothiazine medication by nylidrin hydrochloride. Chu J, Doering MF, Fogel EJ. Int J Neuropsychiatry; 1966 Feb 11; 2(1):53-9. PubMed ID: 5907814 [No Abstract] [Full Text] [Related]
14. Note on the treatment of depression. Denber HC. Can Psychiatr Assoc J; 1966 Feb 11; 11 Suppl():Suppl:141-5. PubMed ID: 5328013 [No Abstract] [Full Text] [Related]
15. Flupenthixol versus haloperidol in acute psychosis. Parent M, Toussaint C. Pharmatherapeutica; 1983 Feb 11; 3(5):354-64. PubMed ID: 6844372 [Abstract] [Full Text] [Related]
17. To the incompatibility of haloperidol with lithium salts. Marhold J, Zimanová J, Lachman M, Král J, Vojtĕchovský M. Act Nerv Super (Praha); 1974 Aug 11; 16(3):199-200. PubMed ID: 4420744 [No Abstract] [Full Text] [Related]